Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up

Smith & Nephew Share Price (SN.)

Show Chart Filters
Time period:
Moving Average:
Compare to:
Price 1,257.50on 17-01-2022 at 16:30:00
Change 0.00 0.00%
Buy 1,256.50
Sell 1,256.00
Sponsored Financial Content
Last Trade: Buy 3,951 at 1,273.951p
Day's Volume: 1,096,657
Last Close: 1,260.50p
Open: 1,271.00p
ISIN: GB0009223206
Day's Range 1,256.00p - 1,287.50p
52wk Range: 1,197.50p - 1,681.50p
Market Capitalisation: £11,063m
VWAP: 0.00p
Shares in Issue: 880m

Recent Trades History Smith & Nephew (SN.)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Delayed publication
17:24:13 - 17-Jan-22
18:08:58 - 17-Jan-22
18:07:06 - 17-Jan-22
17:55:34 - 17-Jan-22
17:38:42 - 17-Jan-22
17:31:17 - 17-Jan-22
17:25:26 - 17-Jan-22
17:25:37 - 17-Jan-22
17:24:03 - 17-Jan-22
17:23:17 - 17-Jan-22

Share Price History for Smith & Nephew

Time period:
Date Open High Low Close
14th Jan 2022 (Fri)1,265.001,278.501,254.001,258.00
13th Jan 2022 (Thu)1,267.001,281.001,252.501,271.25
12th Jan 2022 (Wed)1,339.001,349.001,276.001,277.00
11th Jan 2022 (Tue)1,340.001,357.501,334.001,341.75
10th Jan 2022 (Mon)1,302.501,320.501,292.001,317.75
7th Jan 2022 (Fri)1,301.001,310.501,290.001,298.50
6th Jan 2022 (Thu)1,299.501,311.501,287.501,309.25
5th Jan 2022 (Wed)1,309.501,319.501,304.501,319.00
4th Jan 2022 (Tue)1,316.501,318.001,303.001,308.25
3rd Jan 2022 (Mon)1,,289.00
31st Dec 2021 (Fri)1,273.001,293.501,273.001,289.00
30th Dec 2021 (Thu)1,287.001,299.001,282.501,289.00
29th Dec 2021 (Wed)1,298.001,311.001,284.501,290.00
28th Dec 2021 (Tue)1,,280.75
27th Dec 2021 (Mon)1,,280.75
24th Dec 2021 (Fri)1,276.001,284.501,273.001,280.75
23rd Dec 2021 (Thu)1,277.501,278.501,268.001,274.00
22nd Dec 2021 (Wed)1,257.001,280.501,257.001,269.00
21st Dec 2021 (Tue)1,226.501,249.501,219.501,245.75
20th Dec 2021 (Mon)1,215.001,227.001,204.001,213.50

SN. - Smith & Nephew Investor Summary

Smith & Nephew are presently the UK's largest medical technology company and one of global significance in its specialised field. Established over 150 years ago, the company now operates in over 30 countries worldwide, with their headquarters still being in London, UK. Their main focus revolves around developing and promoting novel products to help physicians treat aging patients with endoscopy techniques, orthopaedic reconstruction, trauma and advanced wound management being at the forefront of their research. The company feel that the increasingly aging population equals a significant growth potential for the already established markets of orthopaedics, endoscopy and wound management around the world.

Today, Smith & Nephew have over 1000 products in their arsenal and generate worldwide sales of over 3.4 billion dollars. They further report that over the last 5 years their revenues have grown from around nineteen hundred million dollars to over thirty three hundred million dollars – a percentage increase of nearly 100%. This success has been helped along by the launch of a new range of ingenious wound dressing products in 2008 and the acquisition of the Swiss company Plus Orthopaedics Holdings AG in 2007. Smith & Nephew research, develop and manufacture a number of new orthopaedic and wound management products each year, many of which quickly become established products within the UK and the US. The share price of this major medtech company has stayed stable for a number of years and continues to rise as new products are launched.

News about Smith & Nephew (SN.)

Smith&Nephew sees 'encouraging start' to 2021

News - Thursday, April 29, 2021

Smith&Nephew has reported an 11.5% rise in Q1 revenue to $1.2billion as all thre......

FTSE drops more than 1% after weak US data

News - Thursday, February 18, 2021

FTSE drops more than 1% after weak US data The FTSE 100 surrendered its gains f......

FTSE 100 Latest

Login to your account

Forgot Password?

Not Registered